Details for New Drug Application (NDA): 213571
✉ Email this page to a colleague
The generic ingredient in ISOTRETINOIN is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
Summary for 213571
Tradename: | ISOTRETINOIN |
Applicant: | Upsher Smith Labs |
Ingredient: | isotretinoin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 213571
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 213571 | ANDA | Upsher-Smith Laboratories, LLC | 0245-0575 | 0245-0575-01 | 3 BLISTER PACK in 1 BOX (0245-0575-01) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0245-0575-89) |
ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 213571 | ANDA | Mayne Pharma | 68308-575 | 68308-575-30 | 3 BLISTER PACK in 1 BOX (68308-575-30) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (68308-575-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
Approval Date: | Apr 12, 2021 | TE: | AB2 | RLD: | No |
Complete Access Available with Subscription